Abstract
Background: Our previous study developed ATRQ beta-001 vaccine, which targets peptide ATR001 from angiotensin II (Ang II) receptor type 1 (AT1R). The ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
